Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1142-1149

  Fiske, Christina T ^a   De Almeida, Alexandre S ^a,b   Shintani, Ayumi K ^a   Kalams, Spyros A ^a   Sterling, Timothy R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RESPONSE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84864563738     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00221-12     Document Type: Article

References (42)

1. American Thoracic Society/Centers for Disease Control and Prevention. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161:S221-S247.
2. Antas PRZ, et al. 2006. Decreased CD4(+) lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J. Allergy Clin. Immunol. 117:916-923.
3. Barnes PF, et al. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489. (Pubitemid 23223442)
4. Castano D, Barrera LF, Rojas M. 2011. Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro. Cell. Immunol. 268:60-67.
5. Centers for Disease Control and Prevention. 2005. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recommend. Rep. 54:1-47.
6. Crowle AJ, Elkins N. 1990. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect. Immun. 58:632-638. (Pubitemid 20072624)
7. Cruz A, et al. 2006. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177:1416-1420. (Pubitemid 44092473)
8. de Almeida AS, Fiske CT, Sterling TR, Kalams SA. 2012. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin. Vaccine Immunol. 19:45-52.
9. Djoba Siawaya JF, et al. 2009. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 47:132-136.
10. Edwards KM, et al. 2001. Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 164:2213-2219. (Pubitemid 34032938)
11. Feng Y, et al. 2011. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect. Immun. 79:229-237.
12. Fiske CT, de Almeida AS, Kalams SA, Sterling TR. 2010. Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro macrophage model that simulates in vivo infection with M. tuberculosis. Am. J. Respir. Crit. Care Med. 181:A3218.
13. Fiske CT, et al. 2010. Black race, sex, and extrapulmonary tuberculosis risk: an observational study. BMC Infect. Dis. 10:16. doi:10.1186/1471-2334-10- 16.
14. Fiske CT, Hamilton CD, Stout JE. 2009. Alcohol use and clinical manifestations of tuberculosis. J. Infect. 58:395-401.
15. Flores-Villanueva PO, et al. 2005. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 202:1649-1658. (Pubitemid 41815871)
16. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129. (Pubitemid 32368031)
17. Goletti D, et al. 2006. Region of difference 1 antigen-specific CD4+memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 194:984-992. (Pubitemid 44454084)
18. Hasan Z, et al. 2009. ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS One 4:e5158. doi:10.1371/journal.pone.0005158.
19. Hasan Z, et al. 2009. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand. J. Immunol. 69:259-267.
20. Hasan Z, et al. 2011. M. tuberculosis sonicate induced IFNgamma, CXCL10 and IL10 can differentiate severity in tuberculosis. Scand. J. Immunol. 75:220-226.
21. Hasan Z, et al. 2005. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol. 6:14. doi:10.1186/1471-2172-6-14.
22. Hirsch CS, et al. 1999. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180:2069-2073.
23. Horsburgh CR. 2004. Priorities for the treatment of latent tuberculosis infection in the United States. N. Engl. J. Med. 350:2060-2067.
24. Hussain R, et al. 2002. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J. Immunol. Methods 264:95-108. (Pubitemid 34615896)
25. Iseman MD. 2000. A clinician's guide to tuberculosis, p 63-96. Lippincott, Williams, and Wilkins, Philadelphia, PA.
26. Jamil B, et al. 2007. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb.) 87:279-287. (Pubitemid 46936246)
27. Jee SH, et al. 2009. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am. J. Epidemiol. 170:1478-1485.
28. Jo EK, et al. 2000. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis. Scand. J. Immunol. 51:209-217.
29. Jo EK, Park JK, Dockrell HM. 2003. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis. 16:205-210. (Pubitemid 36677313)
30. Jones BE, et al. 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148:1292-1297.
31. Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. 2004. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int. J. Tuberc. Lung Dis. 8:658-674. (Pubitemid 38625078)
32. Marin ND, et al. 2010. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb.) 90:252-261.
33. Okamoto Yoshida Y, et al. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184:4414-4422.
34. Porcel JM. 2009. Tuberculous pleural effusion. Lung 187:263-270.
35. Reed WW, Diehl LF. 1991. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch. Intern. Med. 151:501-505.
36. Sai Priya VH, et al. 2009. In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin. Vaccine Immunol. 16:111-115.
37. Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK. 2002. Cytokine polarization in miliary and pleural tuberculosis. J. Clin. Immunol. 22:345-352. (Pubitemid 35305884)
38. Sterling TR, et al. 2001. Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin. Infect. Dis. 33:976-982. (Pubitemid 32907098)
39. Sterling TR, et al. 2007. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics 120:e912-e921. (Pubitemid 47549535)
40. Verbon A, et al. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115:110-113. (Pubitemid 29030371)
41. Wilkinson RJ, et al. 1998. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178:760-768. (Pubitemid 28397224)
42. Wilsher ML, Hagan C, Prestidge R, Wells AU, Murison G. 1999. Human in vitro immune responses to Mycobacterium tuberculosis. Tuber. Lung Dis. 79:371-377.